Comera Life Sciences Holdings, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Dec 2023 | $2 M | No. 3 | Under $2 million | debt, options | SEC | |
| Jul 2023 | $2 M | No. 2 | $2 to $10 million | equity, options | SEC | |
| Jan 2023 | $4 M | No. 1 | $2 to $10 million | equity, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Comera Life Sciences Holdings, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2024).
SEC Form D · Jan 2024
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jan 2024
That is all the official record says: Comera Life Sciences Holdings, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Comera Life Sciences Holdings, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 14 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Jeffrey S. Hackman | Executive officer | Jan 2024 |
| Michael Gerard Campbell | Executive officer | Jan 2024 |
| Robert Patrick Mahoney | Executive officer | Jan 2024 |
| Janice Marie McCourt | Executive officer | Aug 2023 |
| Neal S. Muni | Executive officer | Aug 2023 |
| Dorothy J. Clarke | Director | Jan 2024 |
| Edward Aloysius Sullivan Jr. | Director | Jan 2024 |
| James Patrick Sherblom | Director | Jan 2024 |
| Jeffrey S. Hackman | Director | Jan 2024 |
| Kirsten Roopom Flowers | Director | Jan 2024 |
| Sirshendu Roopom Banerjee | Director | Jan 2024 |
| William A. Wexler | Director | Jan 2024 |
| James Marie Sherblom | Director | Aug 2023 |
| Stuart A. Randle | Director | Aug 2023 |